Common Stock, Shares, Outstanding of RHYTHM PHARMACEUTICALS, INC. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
RHYTHM PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • RHYTHM PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 67,205,321, a 7.7% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 67,205,321 +4,814,667 +7.7% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 66,684,077 +5,247,826 +8.5% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 63,913,185 +2,817,236 +4.6% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 63,494,892 +2,530,424 +4.2% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 62,390,654 +2,964,095 +5% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 61,436,251 +2,346,899 +4% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 61,095,949 +4,199,881 +7.4% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 60,964,468 +4,112,064 +7.2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 59,426,559 +2,814,130 +5% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 59,089,352 +3,333,096 +6% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 56,896,068 +6,441,898 +13% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 56,852,404 +6,458,673 +13% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 56,612,429 +6,328,855 +13% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 55,756,256 +5,487,944 +11% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 50,454,170 +227,431 +0.45% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 50,393,731 +191,973 +0.38% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 50,283,574 +6,047,671 +14% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 50,268,312 +6,063,567 +14% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 50,226,739 +6,111,127 +14% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 50,201,758 +6,205,005 +14% 31 Mar 2021 10-Q 03 May 2021 2021 Q1
Q4 2020 44,235,903 +239,150 +0.54% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 44,204,745 +9,626,181 +28% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 44,115,612 +9,618,070 +28% 30 Jun 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 43,996,753 +9,566,112 +28% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 43,996,753 +9,586,028 +28% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 34,578,564 +196,039 +0.57% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 34,497,542 +324,405 +0.95% 30 Jun 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 34,430,641 +7,146,501 +26% 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 34,410,725 +7,126,585 +26% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 34,382,525 +32,612,223 +1842% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 34,173,137 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 27,284,140 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 27,284,140 +17,087,848 +168% 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q3 2017 1,770,302 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q4 2016 10,196,292 31 Dec 2016 8-K 09 Nov 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.